What this means
This is a study plan that has not started yet, so no results exist. It will test whether semaglutide or tirzepatide, with coaching, changes a biological age score over 6 months.
Plain-English summary written by an AI model from the registry listing.
- Status
- Opening soon
- Who can join
- Ages 40–89
- Where
- 2 sites
The science
- Registered title
- Assessing Biological Aging in a Real-World Medical Weight Loss Program Using the LinAge2 Clinical Clock
- Trial ID
- NCT07444073 ↗
- Phase
- Not applicable
- Study type
- observational
- Conditions
- Aging, Obesity & Overweight
- What is tested
- Not applicable. This is an observational study.
- Sponsor
- National University of Singapore
- Ages
- 40 Years to 89 Years
- Dates
- First posted Mar 2, 2026 · updated Jul 1, 2026
Registry summary
This study examines whether routine treatment with semaglutide or tirzepatide, prescribed with lifestyle coaching in a real-world weight-management program, is associated with changes in biological age measured by the LinAge2 clinical aging clock over 6 months.
Sites (2)
- NOVI Health (T3 Health PTE LTD), Singapore, Singapore
- National University of Singapore, Singapore, Singapore